Table 1. Patient characteristics.
Patients
|
||
---|---|---|
Characteristic | No. | % |
Total | 47 | 100 |
Male | 35 | 74 |
Female | 12 | 26 |
Age (years) | ||
Median | 62 | |
Range | 18–93 | |
Disease at time of commencing IRESSA | ||
Locally recurrent | 29 | 62 |
Metastatica | 18 | 38 |
Histology | ||
Squamous cell carcinoma | 45 | 96 |
UCNTb | 1 | 2 |
Carcinosarcoma | 1 | 2 |
ECOG performance status | ||
0 | 0 | 0 |
1 | 26 | 55 |
2 | 19 | 40 |
3 | 2 | 4 |
Prior therapy (n=43) | ||
Surgery | 22 | 51 |
Radiotherapy | 40 | 93 |
With chemotherapy | 18 | 42 |
Alone (radical or palliative) | 22 | 51 |
Chemotherapy | 27 | 63 |
Radical chemoradiation only | 11 | 26 |
Radical chemoradiation and then for recurrence or metastases | 7 | 16 |
Only for recurrent disease or metastases | 9 | 21 |
These patients may also have had local recurrence simultaneously with metastatic disease.
Undifferentiated carcinoma of nasopharyngeal type.